Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Celldex Therapeutics, Inc. is not a good value stock. Celldex Therapeutics, Inc. is not a good growth stock. Celldex Therapeutics, Inc. is not very popular among insiders. Celldex Therapeutics, Inc. is a mediocre stock to choose.
Log in to see more information.
Celldex Therapeutics, Inc. engages in the research, development, and commercialization of immunother...
CLDX Fundamental Data by TradingView

News

Celldex Therapeutics to Present at Upcoming Investor Conferences
Celldex Therapeutics to Present at Upcoming Investor Conferences

Globe Newswire HAMPTON, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences: 2024...\n more…

Celldex Therapeutics (NASDAQ:CLDX) Rating Reiterated by Cantor Fitzgerald
Celldex Therapeutics (NASDAQ:CLDX) Rating Reiterated by Cantor Fitzgerald

Ticker Report Cantor Fitzgerald reissued their overweight rating on shares of Celldex Therapeutics (NASDAQ:CLDX - Free Report) in a research report released on Monday, Benzinga reports. The brokerage currently has...\n more…

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank

Ticker Report Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) by 40.9% during the second quarter, according to its most recent Form 13F filing...\n more…

Celldex Therapeutics (NASDAQ:CLDX) Trading 4.5% Higher
Celldex Therapeutics (NASDAQ:CLDX) Trading 4.5% Higher

Zolmax Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report)'s stock price was up 4.5% during mid-day trading on Thursday . The company traded as high as $40.36 and last traded at $40.21. Approximately...\n more…

Celldex Therapeutics Target of Unusually High Options Trading (NASDAQ:CLDX)
Celldex Therapeutics Target of Unusually High Options Trading (NASDAQ:CLDX)

Zolmax Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) saw some unusual options trading on Wednesday. Investors purchased 6,226 call options on the stock. This is an increase of 2,865% compared...\n more…

Bullish Two Hundred Day Moving Average Cross - CLDX
Bullish Two Hundred Day Moving Average Cross - CLDX

Market News Video In trading on Monday, shares of Celldex Therapeutics, Inc. (CLDX) crossed above their 200 day moving average of 37.52, changing hands as high as 37.93 per share...\n more…